The rise of Sildenafil initially sparked a surge for major pharmaceutical companies, however recent shifts present a complicated picture for shareholders. Lower-cost versions are eating into revenue, and persistent https://junaidkrdk812248.blogdigy.com/viagra-and-big-pharma-a-volatile-play-66114135